Active	Status	Sponsor type	Region	Phase	Filter
3 Active 1 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
MetaBlok (lsalt peptide) / Arch Biopartners
CATCO, NCT04330690: Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial	Active, not recruiting	3	2900	Canada	Artesunate, Imatinib, Infliximab, Dexamethasone, LSALT Peptide	Sunnybrook Health Sciences Centre, AbbVie, Apotex Inc., World Health Organization, University of British Columbia, Arch Biopartners Inc.	COVID-19	03/24	05/24
NCT04402957: LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19)	Completed	2	61	Canada, US, RoW	LSALT peptide, Metablok, Placebo	Arch Biopartners Inc.	COVID, Severe Acute Respiratory Syndrome, Sars-CoV2, Acute Kidney Injury, Acute Respiratory Distress Syndrome	05/21	06/22
NCT05879432: LSALT Peptide for Prevention or Attenuation of Acute Kidney Injury (AKI) in Patients Undergoing On-Pump Cardiac Surgery	Recruiting	2	240	Canada, RoW	LSALT Peptide, Metablok, Placebo	Arch Biopartners Inc.	Acute Kidney Injury, Cardiac Surgery	08/25	11/25

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
MetaBlok (lsalt peptide) / Arch Biopartners
CATCO, NCT04330690: Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial	Active, not recruiting	3	2900	Canada	Artesunate, Imatinib, Infliximab, Dexamethasone, LSALT Peptide	Sunnybrook Health Sciences Centre, AbbVie, Apotex Inc., World Health Organization, University of British Columbia, Arch Biopartners Inc.	COVID-19	03/24	05/24
NCT04402957: LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19)	Completed	2	61	Canada, US, RoW	LSALT peptide, Metablok, Placebo	Arch Biopartners Inc.	COVID, Severe Acute Respiratory Syndrome, Sars-CoV2, Acute Kidney Injury, Acute Respiratory Distress Syndrome	05/21	06/22
NCT05879432: LSALT Peptide for Prevention or Attenuation of Acute Kidney Injury (AKI) in Patients Undergoing On-Pump Cardiac Surgery	Recruiting	2	240	Canada, RoW	LSALT Peptide, Metablok, Placebo	Arch Biopartners Inc.	Acute Kidney Injury, Cardiac Surgery	08/25	11/25